MX2012012095A - Analogos de tiazolidinadiona. - Google Patents
Analogos de tiazolidinadiona.Info
- Publication number
- MX2012012095A MX2012012095A MX2012012095A MX2012012095A MX2012012095A MX 2012012095 A MX2012012095 A MX 2012012095A MX 2012012095 A MX2012012095 A MX 2012012095A MX 2012012095 A MX2012012095 A MX 2012012095A MX 2012012095 A MX2012012095 A MX 2012012095A
- Authority
- MX
- Mexico
- Prior art keywords
- thiazolidinedione analogues
- thiazolidinedione
- analogues
- nonalcoholic
- afflictions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a análogos de tiazolidinadiona que son útiles para tratar aflicciones del hígado tal como enfermedad no alcohólica de hígado graso (NAFLD) o esteatohepatitis no alcohólica (NASH).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32640010P | 2010-04-21 | 2010-04-21 | |
PCT/US2011/033145 WO2011133611A1 (en) | 2010-04-21 | 2011-04-20 | Thiazolidinedione analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012012095A true MX2012012095A (es) | 2012-12-17 |
Family
ID=44227561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012012095A MX2012012095A (es) | 2010-04-21 | 2011-04-20 | Analogos de tiazolidinadiona. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20130281414A1 (es) |
EP (1) | EP2560615A1 (es) |
JP (1) | JP2013525362A (es) |
KR (1) | KR20130064742A (es) |
CN (1) | CN102946860A (es) |
AU (1) | AU2011242844A1 (es) |
CA (1) | CA2796961A1 (es) |
MX (1) | MX2012012095A (es) |
RU (1) | RU2012149458A (es) |
WO (1) | WO2011133611A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2012006725A (es) | 2009-12-15 | 2012-06-28 | Metabolic Solutions Dev Co Llc | Sales de tiazolidinadiona reductoras de receptores activados por proliferador de peroxisoma (ppar) para el tratamiento de enfermedades metabolicas. |
WO2017181317A1 (en) * | 2016-04-18 | 2017-10-26 | Eli Lilly And Company | Treatment for nonalcoholic steatohepatitis and fibrosis |
WO2019213611A1 (en) | 2018-05-04 | 2019-11-07 | Cirius Therapeutics, Inc. | Thiazolidinedione analogs for the treatment of nafld and metabolic diseases |
WO2020033447A1 (en) * | 2018-08-07 | 2020-02-13 | Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno | Compositions acting as (pro) renin receptor antagonists for the treatment of non-alcoholic fatty liver disease |
WO2020146810A1 (en) * | 2019-01-10 | 2020-07-16 | Cirius Therapeutics, Inc. | Thiazolidinedione analogs for the treatment of nafld and metabolic diseases |
CN112209896B (zh) * | 2019-07-10 | 2023-05-16 | 苏州泽璟生物制药股份有限公司 | 噻唑烷二酮衍生物以及包含其的药物组合物 |
EP4054568A4 (en) * | 2019-11-08 | 2023-12-13 | Cirius Therapeutics, Inc. | THIAZOLIDINDIONE ANALOGS FOR THE TREATMENT OF NAFLD AND METABOLIC DISEASES |
AU2021329339A1 (en) * | 2020-08-18 | 2023-03-09 | Metrea Biosciences, Inc. | Compounds and methods of modulating 17β-hydroxysteroid dehydrogenase type 13 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
US5994341A (en) | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
ES2398313T3 (es) * | 2007-09-14 | 2013-03-15 | Metabolic Solutions Development Company Llc | 5-(4-(2-(3-metoxifenil)-2-oxoetoxi)bencil)tiazolidin-2,4-diona para uso en el tratamiento de la diabetes |
US8722710B2 (en) * | 2007-09-26 | 2014-05-13 | Deuterx, Llc | Deuterium-enriched pioglitazone |
-
2011
- 2011-04-20 EP EP11716784A patent/EP2560615A1/en not_active Withdrawn
- 2011-04-20 KR KR1020127030183A patent/KR20130064742A/ko not_active Application Discontinuation
- 2011-04-20 RU RU2012149458/04A patent/RU2012149458A/ru not_active Application Discontinuation
- 2011-04-20 CA CA2796961A patent/CA2796961A1/en not_active Abandoned
- 2011-04-20 MX MX2012012095A patent/MX2012012095A/es not_active Application Discontinuation
- 2011-04-20 CN CN2011800306435A patent/CN102946860A/zh active Pending
- 2011-04-20 US US13/641,936 patent/US20130281414A1/en not_active Abandoned
- 2011-04-20 JP JP2013506253A patent/JP2013525362A/ja not_active Withdrawn
- 2011-04-20 AU AU2011242844A patent/AU2011242844A1/en not_active Abandoned
- 2011-04-20 WO PCT/US2011/033145 patent/WO2011133611A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2011242844A1 (en) | 2012-11-01 |
US20130281414A1 (en) | 2013-10-24 |
WO2011133611A1 (en) | 2011-10-27 |
EP2560615A1 (en) | 2013-02-27 |
JP2013525362A (ja) | 2013-06-20 |
CN102946860A (zh) | 2013-02-27 |
CA2796961A1 (en) | 2011-10-27 |
KR20130064742A (ko) | 2013-06-18 |
RU2012149458A (ru) | 2014-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012012095A (es) | Analogos de tiazolidinadiona. | |
GEP201706663B (en) | Novel composition for nonalcoholic fatty liver disease (nafld | |
TN2010000140A1 (en) | Compositions and methods for use antibodies against sclerostin | |
IL231512B (en) | Preparations of galacto-rhamnogalacturonate for the treatment of non-alcoholic steatohepatitis and alcoholic fatty liver disease | |
MX2018009945A (es) | Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad. | |
IN2014KN00848A (es) | ||
IL212814A0 (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
GB0917002D0 (en) | Improved shigella blebs | |
MX2014004074A (es) | Metodo de tratamiento de condiciones del higado utilizando antagonistas de notch2. | |
MX2019005082A (es) | Composiciones que comprenden 15-ohepa y metodos para usar las mismas. | |
MX2011014019A (es) | Derivados de diazahomoadamantano y sus metodos de uso. | |
PL2445510T3 (pl) | Kompozycja do leczenia zwyrodnieniowych chorób stawów | |
MY157341A (en) | Methods and compositions for treating lung cancer | |
IL251083A0 (en) | Compounds and preparations for the treatment of cancer | |
SI2605764T1 (sl) | Sestavki za zdravljenje raka | |
WO2012024282A3 (en) | 1,5-diphenyl-penta-1,4-dien-3-one compounds | |
SG178596A1 (en) | Methods of treatment using anti-oxidized ldl antibodies | |
IN2014DN07326A (es) | ||
EP3510014A4 (en) | COMPOSITIONS AND METHODS FOR USE OF GAMMA KETOALDEHYD CATCHERS FOR TREATING, PREVENTING OR IMPROVING NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD, OR DISEASES | |
GB0917745D0 (en) | Compositions for the prevention or treatment of migraine | |
PT2566506T (pt) | Composição de vacina para a prevenção ou tratamento de leishmanioses | |
TN2010000463A1 (en) | Compositions and methods for preparing and using same | |
IL223055A0 (en) | Compositions for the treatment of gynaecological disorders | |
TN2011000013A1 (en) | Amidophenoxyindazoles useful as inhibitors of c-met |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |